Ambrx
Biopharmaceutical innovations
About Ambrx
Ambrx (Nasdaq: AMAM) is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications. The company was spun out of The Scripps Research Institute in 2003 and has several product candidates involving ADCs and other aspects of Ambrx’s protein engineering technology.
Benefits of using Remote First Jobs
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.
Search remote, work from home, 100% online jobs
We help you connect with top remote-first companies.
Hiring remote talent? Post a job